Toripalimab Clinical Trials
101 recruitingDrug
Phase 275Phase 117Phase 312Not Applicable5Early Phase 12Phase 41
Showing 1–20 of 101 trials
Recruiting
Phase 2
Immunotherapy Platform Study in Platinum Resistant High Grade Serous Ovarian Cancer
Ovarian Cancer
Canadian Cancer Trials Group60 enrolled6 locationsNCT04918186
Recruiting
Phase 2
Sun Yat-Sen Treatment Strategy for Enhancing Response in Muscle-invasive Bladder Cancer
Bladder CancerBladder Urothelial Carcinoma
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University80 enrolled1 locationNCT07717242
Recruiting
Phase 1
A Study of CHS-114 (Tagmokitug) in Combination With Toripalimab and/or Other Treatments in Participants With Advanced Solid Tumors
Advanced Solid TumorMetastatic Solid Tumor
Coherus Oncology, Inc.154 enrolled30 locationsNCT06657144
Recruiting
Phase 4
A Study of Toripalimab in Combination With Cisplatin and Gemcitabine in Participants With Recurrent Metastatic Nasopharyngeal Cancer
Nasopharyngeal Cancer Recurrent
Coherus Oncology, Inc.100 enrolled13 locationsNCT06457503
Recruiting
Phase 2
Neoadjuvant High-Intensity Focused Ultrasound (HIFU) Combined With Toripalimab and Chemotherapy for ER-Positive /HER2-Negative Breast Cancer
ER+/HER2- Breast Cancer
Second Affiliated Hospital, School of Medicine, Zhejiang University30 enrolled1 locationNCT06964906
Recruiting
Phase 3
Neoadjuvant RC48 Plus Gemcitabine in HER2-Expressing MIBC
MIBC
Zhiquan Hu170 enrolled22 locationsNCT07693959
Recruiting
Phase 2
Gut Microbiota Modulation for Immunotherapy Resensitization in Advanced Renal Cell Carcinoma
Advanced RCC
Jinling Hospital, China33 enrolled2 locationsNCT07611825
Recruiting
Early Phase 1
An Exploratory Study of Personalized Cancer Vaccine in Adjuvant Therapy of Solid Tumors
Solid Tumor
Ruijin Hospital60 enrolled1 locationNCT07680582
Recruiting
Phase 2
Neoadjuvant SBRT Followed by Nab-Paclitaxel Combined With Toripalimab in HR+/HER2- Breast Cancer
Breast Cancer
Xijing Hospital27 enrolled2 locationsNCT06914440
Recruiting
Phase 2
A Multicenter, Randomized Controlled Phase II Study of Short-Course Radiotherapy Followed by Sequential PD-1 Inhibitor and FOLFOX Chemotherapy Versus Long-Course Chemoradiotherapy for High-Risk Locally Advanced pMMR/MSS Lower Rectal Adenocarcinoma (STAR Trial)
Rectal AdenocarcinomaImmunotherapyHigh-risk Locally Advanced+2 more
Sixth Affiliated Hospital, Sun Yat-sen University76 enrolled1 locationNCT07669220
Recruiting
Phase 2
Gemcitabine + Docetaxel + Toripalimab Induction in Epstein-Barr Virus (EBV) Associated Nasopharyngeal Carcinoma(NPC)
Nasopharyngeal Carcinoma
Stanford University24 enrolled1 locationNCT06592599
Recruiting
Study on MRD Prediction of Efficacy of Toripalimab in the Treatment of High-risk Recurrent Renal Carcinoma
Renal Cell Carcinoma (RCC)
Tianjin Medical University Second Hospital110 enrolled1 locationNCT07657325
Recruiting
Phase 2
EV + Toripalimab vs GC as Neoadjuvant Therapy in Locally Advanced/High-Risk MIBC
Muscle Invasive Bladder Cancer (MIBC)
Peking University Third Hospital58 enrolled1 locationNCT07647289
Recruiting
Phase 2
Phase II Study of JS212/JS213 as Monotherapy and in Combination in Patients With Advanced Malignant Solid Tumors
Advanced malignant solid tumors
Shanghai Junshi Bioscience Co., Ltd.410 enrolled1 locationNCT07480733
Recruiting
Phase 2
LDRT Combined With Toripalimab and Chemotherapy for Recurrent/Metastatic NPC
Nasopharangeal CancerNasopharyngeal Cancinoma (NPC)
Sun Yat-sen University55 enrolled2 locationsNCT07325539
Recruiting
Phase 2
A Phase II Clinical Study Evaluating the Combination Therapy of JS212 in Patients With Advanced Lung Cancer
Advanced Lung Cancer
Shanghai Junshi Bioscience Co., Ltd.864 enrolled1 locationNCT07309276
Recruiting
Phase 3
Neoadjuvant Therapy of SBRT Sequencial With Toripalimab and Chemotherapy in Resectable Stage II-III NSCLC Patients(neoR-TORCH)
Stage II-III Non-small Cell Lung Cancer
Shanghai Chest Hospital478 enrolled1 locationNCT06437977
Recruiting
Phase 2
SBRT and LDRT Combined With PD-1 Antibody and Chemotherapy in r/m Nasopharyngeal Carcinoma
Nasopharyngeal Carcinoma
Sun Yat-sen University148 enrolled1 locationNCT06323239
Recruiting
Phase 3
Chemoradiotherapy Plus Anti-PD1 in Recurrent NPC: A Multicenter, Open-label, Randomised, Controlled, Phase III Trial
Nasopharyngeal Carcinoma
Sun Yat-sen University212 enrolled12 locationsNCT05340491
Recruiting
Phase 2
Perioperative Trial With IO/TKI for Multi-stage Clear Cell Renal Cell Carcinoma
Clear Cell RCC
Jinling Hospital, China75 enrolled1 locationNCT07571551